 | Q8S | Name: | 5-bromo-3-chloro-N-(1-cyclopentyl-2-methyl-1H-imidazol-4-yl)-2-hydroxybenzene-1-sulfonamide | Formula: | C15 H17 Br Cl N3 O3 S | SMILES: | C1CC(CC1)n3cc(NS(c2cc(cc(c2O)Cl)Br)(=O)=O)nc3C | InChi: | InChI=1S/C15H17BrClN3O3S/c1-9-18-14(8-20(9)11-4-2-3-5-11)19-24(22,23)13-7-10(16)6-12(17)15(13)21/h6-8,11,19,21H,2-5H2,1H3 | Definition date: | 2019-10-03 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 5-bromo-3-chloro-N-(1-cyclopentyl-2-methyl-1H-imidazol-4-yl)-2-hydroxybenzene-1-sulfonamide |
|
 | QBM | Name: | 6-methyl-3-(propylsulfanyl)-1,2,4-triazin-5-ol | Formula: | C7 H11 N3 O S | SMILES: | CCCSc1nnc(c(O)n1)C | InChi: | InChI=1S/C7H11N3OS/c1-3-4-12-7-8-6(11)5(2)9-10-7/h3-4H2,1-2H3,(H,8,10,11) | Definition date: | 2019-10-10 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 6-methyl-3-(propylsulfanyl)-1,2,4-triazin-5-ol |
|
 | QBP | Name: | 5-[4-(trifluoromethyl)phenyl]-1H-tetrazole | Formula: | C8 H5 F3 N4 | SMILES: | C(F)(F)(c2ccc(c1nnnn1)cc2)F | InChi: | InChI=1S/C8H5F3N4/c9-8(10,11)6-3-1-5(2-4-6)7-12-14-15-13-7/h1-4H,(H,12,13,14,15) | Definition date: | 2019-10-10 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 5-[4-(trifluoromethyl)phenyl]-1H-tetrazole |
|
 | QF1 | Name: | 5-bromo-3-chloro-N-[1-cyclopentyl-2-(methylsulfonyl)-1H-imidazol-4-yl]-2-hydroxybenzene-1-sulfonamide | Formula: | C15 H17 Br Cl N3 O5 S2 | SMILES: | CS(c2nc(cn2C1CCCC1)NS(c3cc(cc(c3O)Cl)Br)(=O)=O)(=O)=O | InChi: | InChI=1S/C15H17BrClN3O5S2/c1-26(22,23)15-18-13(8-20(15)10-4-2-3-5-10)19-27(24,25)12-7-9(16)6-11(17)14(12)21/h6-8,10,19,21H,2-5H2,1H3 | Definition date: | 2019-10-21 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 5-bromo-3-chloro-N-[1-cyclopentyl-2-(methylsulfonyl)-1H-imidazol-4-yl]-2-hydroxybenzene-1-sulfonamide |
|
 | T9J | Name: | Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide | Formula: | C14 H15 Br N2 O3 | SMILES: | N(C(Cc1ccc(cc1)O)C(=O)NCC#CBr)C(C)=O | InChi: | InChI=1S/C14H15BrN2O3/c1-10(18)17-13(14(20)16-8-2-7-15)9-11-3-5-12(19)6-4-11/h3-6,13,19H,8-9H2,1H3,(H,16,20)(H,17,18)/t13-/m0/s1 | Definition date: | 2020-03-18 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide |
|
 | KB5 | Name: | 6-azanyl-9~{H}-purine-8-thiol | Formula: | C5 H5 N5 S | SMILES: | Nc1ncnc2[nH]c(S)nc12 | InChi: | InChI=1S/C5H5N5S/c6-3-2-4(8-1-7-3)10-5(11)9-2/h1H,(H4,6,7,8,9,10,11) | Definition date: | 2019-05-09 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 6-azanyl-9~{H}-purine-8-thiol |
|
 | KBB | Name: | 2,5-bis(fluoranyl)benzenesulfonamide | Formula: | C6 H5 F2 N O2 S | SMILES: | N[S](=O)(=O)c1cc(F)ccc1F | InChi: | InChI=1S/C6H5F2NO2S/c7-4-1-2-5(8)6(3-4)12(9,10)11/h1-3H,(H2,9,10,11) | Definition date: | 2019-05-09 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2,5-bis(fluoranyl)benzenesulfonamide |
|
 | KBN | Name: | 2-(trifluoromethyl)-9~{H}-purine-6-thiol | Formula: | C6 H3 F3 N4 S | SMILES: | FC(F)(F)c1nc(S)c2nc[nH]c2n1 | InChi: | InChI=1S/C6H3F3N4S/c7-6(8,9)5-12-3-2(4(14)13-5)10-1-11-3/h1H,(H2,10,11,12,13,14) | Definition date: | 2019-05-10 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2-(trifluoromethyl)-9~{H}-purine-6-thiol |
|
 | KBQ | Name: | 2-sulfanylidene-1,7-dihydropyrrolo[2,3-d]pyrimidin-4-one | Formula: | C6 H5 N3 O S | SMILES: | O=C1NC(=S)Nc2[nH]ccc12 | InChi: | InChI=1S/C6H5N3OS/c10-5-3-1-2-7-4(3)8-6(11)9-5/h1-2H,(H3,7,8,9,10,11) | Definition date: | 2019-05-10 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2-sulfanylidene-1,7-dihydropyrrolo[2,3-d]pyrimidin-4-one |
|
 | KBZ | Name: | 4-cyanobenzenesulfonamide | Formula: | C7 H6 N2 O2 S | SMILES: | N[S](=O)(=O)c1ccc(cc1)C#N | InChi: | InChI=1S/C7H6N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,(H2,9,10,11) | Definition date: | 2019-05-10 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 4-cyanobenzenesulfonamide |
|
 | KD8 | Name: | 6,7-dimethyl-2-sulfanylidene-1~{H}-pteridin-4-one | Formula: | C8 H8 N4 O S | SMILES: | Cc1nc2NC(=S)NC(=O)c2nc1C | InChi: | InChI=1S/C8H8N4OS/c1-3-4(2)10-6-5(9-3)7(13)12-8(14)11-6/h1-2H3,(H2,10,11,12,13,14) | Definition date: | 2019-05-14 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 6,7-dimethyl-2-sulfanylidene-1~{H}-pteridin-4-one |
|
 | KFH | Name: | 2,3,5,6-tetrakis(fluoranyl)benzenesulfonamide | Formula: | C6 H3 F4 N O2 S | SMILES: | N[S](=O)(=O)c1c(F)c(F)cc(F)c1F | InChi: | InChI=1S/C6H3F4NO2S/c7-2-1-3(8)5(10)6(4(2)9)14(11,12)13/h1H,(H2,11,12,13) | Definition date: | 2019-05-20 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2,3,5,6-tetrakis(fluoranyl)benzenesulfonamide |
|
 | JUT | Name: | 4-[3,4-bis(fluoranyl)phenyl]-1,3-thiazol-2-amine | Formula: | C9 H6 F2 N2 S | SMILES: | Nc1scc(n1)c2ccc(F)c(F)c2 | InChi: | InChI=1S/C9H6F2N2S/c10-6-2-1-5(3-7(6)11)8-4-14-9(12)13-8/h1-4H,(H2,12,13) | Definition date: | 2019-04-02 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 4-[3,4-bis(fluoranyl)phenyl]-1,3-thiazol-2-amine |
|
 | L7T | Name: | 2,3,4,5,6-pentafluorobenzenesulfonamide | Formula: | C6 H2 F5 N O2 S | SMILES: | N[S](=O)(=O)c1c(F)c(F)c(F)c(F)c1F | InChi: | InChI=1S/C6H2F5NO2S/c7-1-2(8)4(10)6(15(12,13)14)5(11)3(1)9/h(H2,12,13,14) | Definition date: | 2019-07-26 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2,3,4,5,6-pentakis(fluoranyl)benzenesulfonamide |
|
 | M0J | Name: | N-[(2S)-2-hydroxypropyl]-N'-phenylurea | Formula: | C10 H14 N2 O2 | SMILES: | N(C(=O)NCC(O)C)c1ccccc1 | InChi: | InChI=1S/C10H14N2O2/c1-8(13)7-11-10(14)12-9-5-3-2-4-6-9/h2-6,8,13H,7H2,1H3,(H2,11,12,14)/t8-/m0/s1 | Definition date: | 2019-03-15 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | N-[(2S)-2-hydroxypropyl]-N'-phenylurea |
|
 | M4H | Name: | 5-oxidanyl-4-oxidanylidene-1-[(1-pyrrolo[2,3-b]pyridin-1-ylcyclopentyl)methyl]pyridine-3-carboxylic acid | Formula: | C19 H19 N3 O4 | SMILES: | OC(=O)C1=CN(CC2(CCCC2)n3ccc4cccnc34)C=C(O)C1=O | InChi: | InChI=1S/C19H19N3O4/c23-15-11-21(10-14(16(15)24)18(25)26)12-19(6-1-2-7-19)22-9-5-13-4-3-8-20-17(13)22/h3-5,8-11,23H,1-2,6-7,12H2,(H,25,26) | Definition date: | 2019-10-03 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 5-oxidanyl-4-oxidanylidene-1-[(1-pyrrolo[2,3-b]pyridin-1-ylcyclopentyl)methyl]pyridine-3-carboxylic acid |
|
 | U0M | Name: | 5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine | Formula: | C9 H12 F N3 S | SMILES: | C=1CCN(CC=1F)Cc2nnc(C)s2 | InChi: | InChI=1S/C9H12FN3S/c1-7-11-12-9(14-7)6-13-4-2-3-8(10)5-13/h3H,2,4-6H2,1H3 | Definition date: | 2020-04-08 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine |
|
 | U0P | Name: | N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea | Formula: | C10 H15 N3 O2 | SMILES: | C(N(C)Cc1noc(c1)C)(NC2CC2)=O | InChi: | InChI=1S/C10H15N3O2/c1-7-5-9(12-15-7)6-13(2)10(14)11-8-3-4-8/h5,8H,3-4,6H2,1-2H3,(H,11,14) | Definition date: | 2020-04-08 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea |
|
 | U0S | Name: | (5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane | Formula: | C11 H15 N3 O | SMILES: | C3CC2(CN(c1nccnc1)CC2)CO3 | InChi: | InChI=1S/C11H15N3O/c1-5-14(10-7-12-3-4-13-10)8-11(1)2-6-15-9-11/h3-4,7H,1-2,5-6,8-9H2/t11-/m0/s1 | Definition date: | 2020-04-08 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | (5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane |
|
 | U0V | Name: | 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide | Formula: | C14 H13 F N2 O | SMILES: | c2(CCNC(c1c(F)cccc1)=O)ccncc2 | InChi: | InChI=1S/C14H13FN2O/c15-13-4-2-1-3-12(13)14(18)17-10-7-11-5-8-16-9-6-11/h1-6,8-9H,7,10H2,(H,17,18) | Definition date: | 2020-04-08 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide |
|
 | U1V | Name: | 1-(4-fluoro-2-methylphenyl)methanesulfonamide | Formula: | C8 H10 F N O2 S | SMILES: | c1cc(CS(N)(=O)=O)c(C)cc1F | InChi: | InChI=1S/C8H10FNO2S/c1-6-4-8(9)3-2-7(6)5-13(10,11)12/h2-4H,5H2,1H3,(H2,10,11,12) | Definition date: | 2020-04-08 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 1-(4-fluoro-2-methylphenyl)methanesulfonamide |
|
 | K5W | Name: | 2,3-bis(fluoranyl)benzenesulfonamide | Formula: | C6 H5 F2 N O2 S | SMILES: | N[S](=O)(=O)c1cccc(F)c1F | InChi: | InChI=1S/C6H5F2NO2S/c7-4-2-1-3-5(6(4)8)12(9,10)11/h1-3H,(H2,9,10,11) | Definition date: | 2019-04-29 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 2,3-bis(fluoranyl)benzenesulfonamide |
|
 | C6O | Name: | 6-(2-chloranyl-3-fluoranyl-phenyl)-5-methyl-2-[[3-methyl-4-(4-methylpiperazin-1-yl)phenyl]amino]-8-[(3S)-1-propanoylpiperidin-3-yl]pyrido[2,3-d]pyrimidin-7-one | Formula: | C34 H39 Cl F N7 O2 | SMILES: | CCC(=O)N1CCC[CH](C1)N2C(=O)C(=C(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc23)c6cccc(F)c6Cl | InChi: | InChI=1S/C34H39ClFN7O2/c1-5-29(44)42-13-7-8-24(20-42)43-32-26(22(3)30(33(43)45)25-9-6-10-27(36)31(25)35)19-37-34(39-32)38-23-11-12-28(21(2)18-23)41-16-14-40(4)15-17-41/h6,9-12,18-19,24H,5,7-8,13-17,20H2,1-4H3,(H,37,38,39)/t24-/m0/s1 | Definition date: | 2019-04-11 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | 6-(2-chloranyl-3-fluoranyl-phenyl)-5-methyl-2-[[3-methyl-4-(4-methylpiperazin-1-yl)phenyl]amino]-8-[(3~{S})-1-propanoylpiperidin-3-yl]pyrido[2,3-d]pyrimidin-7-one |
|
 | OSN | Name: | (4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one | Formula: | C25 H31 N3 O2 | SMILES: | COc1ccc2CCCN(CCCC=Cc3cccc4NC(=O)C[CH](C)Nc34)c2c1 | InChi: | InChI=1S/C25H31N3O2/c1-18-16-24(29)27-22-11-6-9-20(25(22)26-18)8-4-3-5-14-28-15-7-10-19-12-13-21(30-2)17-23(19)28/h4,6,8-9,11-13,17-18,26H,3,5,7,10,14-16H2,1-2H3,(H,27,29)/b8-4+/t18-/m1/s1 | Definition date: | 2020-04-01 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | (4~{R})-6-[(~{E})-5-(7-methoxy-3,4-dihydro-2~{H}-quinolin-1-yl)pent-1-enyl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one |
|
 | OSQ | Name: | (3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide | Formula: | C22 H24 F2 N4 O2 | SMILES: | C[CH]1Nc2c(NC1=O)cccc2C(=O)NCC(F)(F)CN3CCCc4ccccc34 | InChi: | InChI=1S/C22H24F2N4O2/c1-14-20(29)27-17-9-4-8-16(19(17)26-14)21(30)25-12-22(23,24)13-28-11-5-7-15-6-2-3-10-18(15)28/h2-4,6,8-10,14,26H,5,7,11-13H2,1H3,(H,25,30)(H,27,29)/t14-/m1/s1 | Definition date: | 2020-04-01 | Last modified: | 2020-04-10 | Release date: | 2020-04-15 | Identifier: | (3~{R})-~{N}-[3-(3,4-dihydro-2~{H}-quinolin-1-yl)-2,2-bis(fluoranyl)propyl]-3-methyl-2-oxidanylidene-3,4-dihydro-1~{H}-quinoxaline-5-carboxamide |
|